Post-approval studies (Phase 4)Ended earlyNCT01128114
What this trial is testing
Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy
Who this might be right for
Acute Bipolar Mania
AstraZeneca 32